Glycaemic control in Australia and New Zealand before and after the NICE-SUGAR trial: A translational study

Critical Care

Volumn 17, Issue 5, 2013, Pages

  Kaukonen, Kirsi Maija ^a   Bailey, Michael ^a   Pilcher, David ^a,b,c   Orford, Neil ^a,d   Finfer, Simon ^e   Bellomo, Rinaldo ^a  

^a MONASH UNIVERSITY   (Australia)

^b Australian and New Zealand Intensive Care Society   (Australia)

^c ALFRED HOSPITAL   (Australia)

^d GEELONG HOSPITAL   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; INSULIN;

ARTICLE; AUSTRALIA AND NEW ZEALAND; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DISEASE SEVERITY; GLYCEMIC CONTROL; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; ADULT; AGED; ALGORITHM; ANALYSIS; APACHE; AUSTRALIA; BLOOD; CLINICAL TRIAL; CRITICAL ILLNESS; DIABETES MELLITUS; EPIDEMIOLOGY; FEMALE; GLUCOSE BLOOD LEVEL; INTENSIVE CARE; MALE; MIDDLE AGED; MULTICENTER STUDY; NEW ZEALAND; SURVIVAL RATE; TRANSLATIONAL RESEARCH; TREATMENT OUTCOME;

ADULT; AGED; ALGORITHMS; APACHE; AUSTRALIA; BLOOD GLUCOSE; CRITICAL ILLNESS; DIABETES MELLITUS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE; MALE; MIDDLE AGED; NEW ZEALAND; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSLATIONAL MEDICAL RESEARCH; TREATMENT OUTCOME;

EID: 84884732457     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13030     Document Type: Article

References (28)

1. Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response!. Crit Care 2013, 17:305. 10.1186/cc12514, 23470218.
2. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003, 290:2041-2047. 10.1001/jama.290.15.2041, 14559958.
3. Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma 2004, 56:1058-1062. 10.1097/01.TA.0000123267.39011.9F, 15179246.
4. Christiansen C, Toft P, Jorgensen HS, Andersen SK, Tonnesen E. Hyperglycaemia and mortality in critically ill patients. A prospective study. Intensive Care Med 2004, 30:1685-1688.
5. Siegelaar SE, Hermanides J, Oudemans-van Straaten HM, van der Voort PH, Bosman RJ, Zandstra DF, DeVries JH. Mean glucose during ICU admission is related to mortality by a U-shaped curve in surgical and medical patients: a retrospective cohort study. Crit Care 2010, 14:R224. 10.1186/cc9369, 3219982, 21143980.
6. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med 2001, 345:1359-1367. 10.1056/NEJMoa011300, 11794168.
7. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med 2006, 354:449-461. 10.1056/NEJMoa052521, 16452557.
8. The NICE-SUGAR Study Investigators Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360:1283-1297. The NICE-SUGAR Study Investigators.
9. Ling Y, Li X, Gao X. Intensive versus conventional glucose control in critically ill patients: a meta-analysis of randomized controlled trials. Eur J Intern Med 2012, 23:564-574. 10.1016/j.ejim.2012.02.013, 22863436.
10. The NICE-SUGAR Study Investigators Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012, 367:1108-1118. The NICE-SUGAR Study Investigators.
11. Evans TW. Hemodynamic and metabolic therapy in critically ill patients. N Engl J Med 2001, 345:1417-1418. 10.1056/NEJM200111083451910, 11794176.
12. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM. Surviving Sepsis Campaign Management Guidelines Committee Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004, 32:858-873. Erratum in: Crit Care Med 2004, 32:1448. Dosage error in article text. Crit Care Med 2004, 32:2169-2170., 10.1097/01.CCM.0000117317.18092.E4, 15090974, Surviving Sepsis Campaign Management Guidelines Committee.
13. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL, et al. International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327. Erratum in: Crit Care Med 2008, 36:1394-1396, 10.1097/01.CCM.0000298158.12101.41, 18158437, International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine.
14. Malhotra A. Intensive insulin in intensive care. N Engl J Med 2006, 354:516-518. 10.1056/NEJMe058304, 2287193, 16452564.
15. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R. Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013, 39:165-228. 10.1007/s00134-012-2769-8, 23361625, Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup.
16. Jacobi J, Bircher N, Krinsley J, Agus M, Braithwaite SS, Deutschman C, Freire AX, Geehan D, Kohl B, Nasraway SA, Rigby M, Sands K, Schallom L, Taylor B, Umpierrez G, Mazuski J, Schunemann H. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med 2012, 40:3251-3276. 10.1097/CCM.0b013e3182653269, 23164767.
17. Mitchell I, Finfer S, Bellomo R, Higlett T. ANZICS clinical trials Group Glucose Management Investigators Management of blood glucose in the critically ill in Australia and New Zealand: a practice survey and inception cohort study. Intensive Care Med 2006, 32:867-874. 10.1007/s00134-006-0135-4, 16622639, ANZICS clinical trials Group Glucose Management Investigators.
18. Stow PJ, Hart GK, Higlett T, George C, Herkes R, McWilliam D, Bellomo R. for the ANZIC Database Management Committee Development and implementation of a high-quality clinical database: the Australian and New Zealand Intensive Care Society Adult Patient Database. J Crit Care 2006, 21:133-141. 10.1016/j.jcrc.2005.11.010, 16769456, for the ANZIC Database Management Committee.
19. Egi M, Bellomo R, Stachowski E, French CJ, Hart G, Stow P. Blood glucose on day of intensive care unit admission as a surrogate of subsequent glucose control in intensive care. J Crit Care 2006, 21:197-202. 10.1016/j.jcrc.2006.03.003, 16769468.
20. ANZICS-CORE Australian and New Zealand Intensive Care Society Centre for Outcome and Resource Evaluation (CORE) 2011, Annual Report 2010-11 http://www.anzics.com.au/core/reports, ANZICS-CORE.
21. ANZICS Adult Patient Database, Training Workshop 2012, http://www.anzics.com.au/apd/apd-education, ANZICS.
22. Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Hegarty C, Bailey M. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med 2008, 36:2249-2255. 10.1097/CCM.0b013e318181039a, 18664780.
23. Bagshaw SM, Egi M, George C, Bellomo R. Australia New Zealand Intensive Care Society Database Management Committee Early blood glucose control and mortality in critically ill patients in Australia. Crit Care Med 2009, 37:463-470. 10.1097/CCM.0b013e318194b097, 19114915, Australia New Zealand Intensive Care Society Database Management Committee.
24. Brunkhorst FM, Engel C, Ragaller M, Welte T, Rossaint R, Gerlach H, Mayer K, John S, Stuber F, Weiler N, Oppert M, Moerer O, Bogatsch H, Reinhart K, Loeffler M, Hartog C. German Sepsis Competence Network (SepNet) Practice and perception-a nationwide survey of therapy habits in sepsis. Crit Care Med 2008, 36:2719-2725. 10.1097/CCM.0b013e318186b6f3, 18766100, German Sepsis Competence Network (SepNet).
25. Lenfant C. Shattuck lecture-clinical research to clinical practice-lost in translation?. N Engl J Med 2003, 349:868-874. 10.1056/NEJMsa035507, 12944573.
26. Patel P, White DL, Deswal A. Translation of clinical trial results into practice: temporal patterns of beta-blocker utilization for heart failure at hospital discharge and during ambulatory follow-up. Am Heart J 2007, 153:515-522. 10.1016/j.ahj.2007.01.037, 17383287.
27. Ilan R, Fowler RA, Geerts R, Pinto R, Sibbald WJ, Martin CM. Knowledge translation in critical care: factors associated with prescription of commonly recommended best practices for critically ill patients. Crit Care Med 2007, 35:1696-1702. 10.1097/01.CCM.0000269041.05527.80, 17522582.
28. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006, 105:244-252. 10.1097/00000542-200608000-00006, 16871057.